Impact of metformin use on the recurrence of hepatocellular carcinoma after initial liver resection in diabetic patients

BACKGROUND: Metformin is proposed to have chemopreventive effect of various cancer currently. However, the anti-cancer effect of metformin for diabetic patients with hepatocellular carcinoma (HCC) undergoing liver resection remains unclear. The aim of our cohort study was to assess whether metformin...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Wei-Ru, Wang, Chih-Chi, Tsai, Meng-Yun, Chou, Chen-Kai, Liu, Yueh-Wei, Wu, Yi-Ju, Lin, Ming-Tsung, Chen, Kuang-Den, Chuang, Ching-Hui, Huang, Pao-Yuan, Hu, Tsung-Hui, Tsai, Ming-Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932176/
https://www.ncbi.nlm.nih.gov/pubmed/33661912
http://dx.doi.org/10.1371/journal.pone.0247231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932176/
https://www.ncbi.nlm.nih.gov/pubmed/33661912
http://dx.doi.org/10.1371/journal.pone.0247231

Ejemplares similares